spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 12 Jun 2012
Tokai Pharmaceuticals’ Galeterone Receives Fast Track Designation from the FDA for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Jun 2012
Genzyme Submits Applications to FDA and EMA for Approval of LEMTRADA(TM) (alemtuzumab) for Multiple Sclerosis
Biopharmaceuticals Neurology FDA Regulatory
 HSMN NewsFeed - 8 Jun 2012
Blaze Bioscience Raises $5.0 Million in Series A Financing
Biopharmaceuticals Oncology Surgery Venture Capital
 HSMN NewsFeed - 7 Jun 2012
GSK and XenoPort Receive FDA Approval for Horizant(R) for Postherpetic Neuralgia
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jun 2012
OxThera Resumes Clinical Development of Hyperoxaluria Therapy
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2012
Achillion Announces Resignation of Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2012
Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA(R) (Adalimumab) in Patients with Active Peripheral Spondyloarthritis
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2012
Abbott Announces 10-Year Data Evaluating HUMIRA(R) (Adalimumab) for Patients with Long-Standing Moderate-to-Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2012
Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA(R) (Adalimumab) in Patients with Active Non-radiographic Axial Spondyloarthritis
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2012
ORENCIA(R) (abatacept) Demonstrates Comparable Efficacy to Humira(R) (adalimumab) in Patients with Moderate to Severe Rheumatoid Arthritis in First Head-to-Head Study of These Agents
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2012
Neuralstem Updates ALS Stem Cell Trial Progress; Emory University Institutional Review Board Approves Amendment
Biopharmaceuticals Regenerative Medicine Neurology
 HSMN NewsFeed - 5 Jun 2012
Kinex Pharmaceuticals Appoints Dr. Jean-Pierre Sommadossi to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2012
Ceptaris Secures $10 Million in Series D-1 Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Jun 2012
Abbott Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2012
Alimera Sciences' ILUVIEN(R) Receives Marketing Authorization in Portugal for the Treatment of Chronic Diabetic Macular Edema
Biopharmaceuticals Ophthalmology Drug Delivery Regulatory
 HSMN NewsFeed - 5 Jun 2012
Former Pfizer Worldwide Business Development Director Joins Australian Drug Development Company Agenix
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2012
Formula Pharmaceuticals Appoints Morton Collins to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Jun 2012
AcelRx Pharmaceuticals Completes Private Placement of $10.0 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jun 2012
Hi-Tech Pharmacal Acquires Rights to the Cormax(R) Brand for its ECR Pharmaceuticals Subsidiary
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 4 Jun 2012
Cees Heiman Joins The Medicines Company to Lead Europe and Middle East Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2012
Orexo acquires US commercial rights of Abstral and ProStrakan acquires the corresponding rights in the EU and rest of the world
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 4 Jun 2012
Phase 3 Data on Regorafenib Met Primary Endpoint Showing Significant Improvement in Progression-Free Survival in Patients with GIST
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2012
Phase III Data on Bayer's Regorafenib Met Primary Endpoint Showing Significant Improvement in Progression-Free Survival in Patients with GIST
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2012
Afatinib* delivers unprecedented first line efficacy in patients with EGFR mutation positive lung cancer in registration trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2012
Aeolus Pharmaceuticals Announces AEOL 10150 Reduces Lung Damage After Neupogen(R) Treatment Following Radiation Exposure
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2012
Cardinal Health to Manufacture, Distribute Eli Lilly and Company's Brain Imaging Agent Amyvid(TM) (Florbetapir F 18 Injection)
Biopharmaceuticals Radiology Neurology
 HSMN NewsFeed - 1 Jun 2012
Genzyme Reports Positive Top-Line Results of TOWER, a Pivotal Phase III Trial for AUBAGIO(TM)* (teriflunomide) in Relapsing Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 May 2012
Catabasis Pharmaceuticals Appoints Henry Rath to Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2012
New Data Showed LIVALO(R) (pitavastatin) Met Primary Endpoint of LDL-C Reduction When Compared with Pravastatin
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 May 2012
Cell Therapeutics' Pixuvri(R) Phase 3 Clinical Trial Results Published in The Lancet Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2012
Polynoma Appoints John Chiplin, Ph.D., Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 May 2012
Watson Announces Lidoderm(R) Patent Challenge Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 May 2012
Eisai Gains Positive CHMP Opinion for Fycompa(R) (perampanel) First in a New Class of Treatment for Partial Onset Epilepsy
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 25 May 2012
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 May 2012
Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2012
Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 May 2012
Zurex Pharma Inc. Secures $6.2 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 May 2012
APP Pharmaceuticals Acquires Three Products from Nexus
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 23 May 2012
PPD Names David Simmons Chairman and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2012
Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2012
Veloxis Pharmaceuticals announces a restructuring of the company to support and strengthen strategic focus on LCP-Tacro(TM) and announces changes to management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2012
FDA Approves Levemir(R) for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 22 May 2012
EnVivo Pharmaceuticals Appoints Alfred Sandrock, M.D., Ph.D., to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 22 May 2012
Talon Therapeutics Appoints Head of Commercial Operations and Planning
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 22 May 2012
Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2012
Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 May 2012
Opexa Therapeutics Announces Tcelna(TM) as New Brand Name for MS Therapy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 May 2012
GenVec Appoints Cynthia Collins as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2012
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim(R) in the U.S.
Biopharmaceuticals Urology
 HSMN NewsFeed - 18 May 2012
Achillion Announces Executive Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2012
Northwest Bio Provides Update On DCVax(R)-L Brain Cancer Trial
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 May 2012
Epizyme Announces Appointment of Eric Hedrick, M.D., as Chief Medical Officer
Biopharmaceuticals Personalized Medicine Personnel
 HSMN NewsFeed - 16 May 2012
Insmed Appoints Donald J. Hayden, Jr. as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2012
Piramal Healthcare Limited to Acquire Decision Resources Group
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 May 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2012
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2012
New Executive Vice President Commercial Appointed
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2012
FDA Grants Fast Track Designation to Ohr Pharmaceutical's Squalamine Eye Drops for the Treatment of Wet-AMD
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 14 May 2012
Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2012
Lannett Company Adds Paul Taveira to Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 11 May 2012
CellTherapeutics’ Pixuvri(R) Approved in EU as Monotherapy to Treat Adult Patients with Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 May 2012
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 May 2012
AmerisourceBergen Names Tim G. Guttman Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2012
Ampio Pharmaceuticals Reports Pre-IND Meeting With the FDA to Obtain Clinical Path Guidance for Ampion(TM) for the Treatment of Chronic Pain of Osteoarthritis of the Knee and Schedules May 16th Webcast to Update Shareholders
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 May 2012
Takeda Announces GEMINI II Trial of Vedolizumab in Patients with Moderately to Severely Active Crohn’s Disease Met Primary Endpoints of Improvement in Clinical Remission in Induction and Maintenance Phases
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 10 May 2012
SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows Similar Safety Profile When Compared to Budesonide Monotherapy in African-American Patients with Asthma
Biopharmaceuticals
 HSMN NewsFeed - 10 May 2012
Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2012
Tris Pharma Announces Management Additions, Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2012
Galena Biopharma Announces Expansion of Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 May 2012
RXi Pharmaceuticals Appoints Industry Veteran Dr. Geert Cauwenbergh as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2012
Janssen Research & Development Submits Supplemental New Drug Application to U.S. FDA for XARELTO(R) (rivaroxaban) to Reduce the Risk of Stent Thrombosis in Patients with Acute Coronary Syndrome
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 8 May 2012
Sutro Closes $16.5 Million Second Tranche of Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 May 2012
Ruga Corporation Expands Management Team to Advance Its Adaptive Response Therapeutics for Cancer Patients
Biopharmaceuticals Personalized Medicine Personnel
 HSMN NewsFeed - 7 May 2012
KYTHERA Biopharmaceuticals Announces Presentation of Positive Results from First of Two ATX-101 European Phase III Trials for Reduction of Submental Fat
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 7 May 2012
New Phase III Data Show Agile Therapeutics' Low-Dose Patch Is Comparable to Combination Oral Contraceptive in a Comparator Study
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 May 2012
Pfizer Reports Top-Line Results From Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy
Biopharmaceuticals
 HSMN NewsFeed - 4 May 2012
Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic Pain Associated With HIV Neuropathy
Biopharmaceuticals
 HSMN NewsFeed - 3 May 2012
Five Prime Therapeutics Announces the Promotion of Aron Knickerbocker to Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2012
Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 3 May 2012
CorMedix Strengthens Management Team with Addition of Randy Milby as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2012
Creabilis Appoints Dr Simon Russell as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2012
Genentech Reports Positive Study of ACTEMRA Given by Subcutaneous Injection
Biopharmaceuticals
 HSMN NewsFeed - 2 May 2012
Acella Pharmaceuticals, LLC, Announces Approval of Generic Gabapentin Oral Solution
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 May 2012
Gentium Appoints PharmaSwiss, S.A. as Exclusive Distributor of Defibrotide in Central and Eastern European Countries
Biopharmaceuticals Distribution
 HSMN NewsFeed - 2 May 2012
Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2012
Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO(TM) (taliglucerase alfa) For The Treatment Of Gaucher Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 May 2012
Acella Pharmaceuticals Announces a New Addition to the Commercial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2012
Pfizer Inc. Issues Statement Regarding Pending Court Case
Biopharmaceuticals Litigation
 HSMN NewsFeed - 30 Apr 2012
Eisai Inc. Announces Appointment Of Senior Vice President And General Counsel, Allen Waxman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Apr 2012
Baxter Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at AAN Annual Meeting
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Apr 2012
Watson Announces Restructuring of Senior Leadership to Support Expanded Global Businesses
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Apr 2012
Novo Nordisk plans 15 percent expansion of U.S. work force in 2012
Biopharmaceuticals
 HSMN NewsFeed - 27 Apr 2012
New Drug Application for Arzerra Submitted in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Apr 2012
Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 26 Apr 2012
Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Apr 2012
Epizyme Forms Strategic Partnership with Industry Leader in Epigenetic Therapies, Celgene Corporation, to Develop Personalized Therapeutics for Genetically-Defined Cancers
Biopharmaceuticals Oncology Personalized Medicine
 HSMN NewsFeed - 25 Apr 2012
Threshold Pharmaceuticals Appoints Robert Simon as Senior Vice President of Regulatory Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Apr 2012
Coronado Biosciences Promotes Karin Hehenberger, M.D., Ph.D., to Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2012
Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Apr 2012
Ipsen Pursues Its Development in the United States with the Opening of Its New Commercial Headquarters in New Jersey (NJ)
Biopharmaceuticals
 HSMN NewsFeed - 24 Apr 2012
ILUVIEN(R) Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema
Biopharmaceuticals Ophthalmology Drug Delivery Regulatory
 HSMN NewsFeed - 24 Apr 2012
Genta Appoints Dr. Brian Leyland-Jones and Richard J. Moran to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Apr 2012
miRagen Therapeutics Secures $20 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Apr 2012
S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2012
Oligomerix, Inc. Completes $2 Million Series A Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 23 Apr 2012
Kolltan Pharmaceuticals Appoints Gerald McMahon, Ph.D., President & Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Apr 2012
AstraZeneca to Acquire Ardea Biosciences for $1.26 Billion Including Lead Product Lesinurad in Phase III Development for Gout
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Apr 2012
Pfizer To Divest Nutrition Business To Nestlé
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 20 Apr 2012
VIVUS Appoints Ernest Mario, Ph.D. to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Apr 2012
EnVivo Pharmaceuticals Names Christopher L. Burnley Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2012
Avion Pharmaceuticals, LLC Names Michael Sullivan as new VP, Sales and Marketing
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 18 Apr 2012
Favorable Ruling by United States Supreme Court on Prandin(R) Litigation
Biopharmaceuticals Endocrinology Generics Litigation
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!